Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 6;8(2):161.
doi: 10.3390/jof8020161.

Association of COVID-19-Associated Pulmonary Aspergillosis with Cytomegalovirus Replication: A Case-Control Study

Affiliations

Association of COVID-19-Associated Pulmonary Aspergillosis with Cytomegalovirus Replication: A Case-Control Study

Jorge Calderón-Parra et al. J Fungi (Basel). .

Abstract

Introduction: Cytomegalovirus (CMV) infection is a well-known factor associated with invasive aspergillosis in immunocompromised hosts. However, its association with COVID-19-associated pulmonary aspergillosis (CAPA) has not been described. We aimed to examine the possible link between CMV replication and CAPA occurrence. Methods: A single-center, retrospective case-control study was conducted. A case was defined as a patient diagnosed with CAPA according to 2020 ECMM/ISHAM consensus criteria. Two controls were selected for each case among critically ill COVID-19 patients. Results: In total, 24 CAPA cases were included, comprising 14 possible CAPA and 10 probable CAPA. Additionally, 48 matched controls were selected. CMV replication was detected more frequently in CAPA than in controls (75.0% vs. 35.4%, p = 0.002). Probable CMV end-organ disease was more prevalent in CAPA (20.8% vs. 4.2%, p = 0.037). After adjusting for possible confounding factors, CMV replication persisted strongly associated with CAPA (OR 8.28 95% CI 1.90-36.13, p = 0.005). Among 11 CAPA cases with CMV PCR available prior to CAPA, in 9 (81.8%) cases, CMV replication was observed prior to CAPA diagnosis. Conclusions: Among critically ill COVID-19 patients, CMV replication was associated with CAPA and could potentially be considered a harbinger of CAPA. Further studies are needed to confirm this association.

Keywords: CAPA; COVID-associated pulmonary aspergillosis; cytomegalovirus infection; prevalence; risk factors.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Peak CMV-DNA viral load among patients with CMV replication according to the diagnosis of pulmonary aspergillosis. Viral load is expressed in UI/mL (0.91 UI/mL equals 1 copy/mL). and represented in a linear scale. CMV: cytomegalovirus.
Figure 2
Figure 2
CMV-DNA viral load in patients with CMV replication according to 2020 ECMM/ISHAM consensus criteria classification of COVID-associated pulmonary aspergillosis and controls. Viral load is expressed in UI/mL (0.91 UI/mL equals 1 copy/mL) and represented in in a linear scale. CMV: cytomegalovirus. * represents an individual patient with a unusual high CMV-DNA viral load within controls.

References

    1. Koehler P., Cornely O.A., Böttiger B.W., Dusse F., Eichenauer D.A., Fuchs F., Hallek M., Jung N., Klein F., Persigehl T., et al. COVID-19 associated pulmonary aspergillosis. Mycoses. 2020;63:528–534. doi: 10.1111/myc.13096. - DOI - PMC - PubMed
    1. Bartoletti M., Pascale R., Cricca M., Rinaldi M., Maccaro A., Bussini L., Fornaro G., Tonetti T., Pizzilli G., Francalanci E., et al. Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: A prospective study. Clin. Infect. Dis. 2021;73:e3606–e3614. doi: 10.1093/cid/ciaa1065. - DOI - PMC - PubMed
    1. Mitaka H., Kuno T., Takagi H., Patrawalla P. Incidence and mortality of COVID-19-associated pulmonary aspergillosis: A systematic review and meta-analysis. Mycoses. 2021;64:993–1001. doi: 10.1111/myc.13292. - DOI - PMC - PubMed
    1. Arastehfar A., Carvalho A., van de Veerdonk F.L., Jenks J.D., Koehler P., Krause R., Cornely O.A., Perlin D.S., Las-Flörl C., Hoenigl M. COVID-19 Associated Pulmonary Aspergillosis (CAPA)-From Immunology to Treatment. J. Fungi Basel Switz. 2020;6:E91. doi: 10.3390/jof6020091. - DOI - PMC - PubMed
    1. Abdoli A., Falahi S., Kenarkoohi A. COVID-19-associated opportunistic infections: A snapshot on the current reports. Clin. Exp. Med. 2021:1–20. doi: 10.1007/s10238-021-00751-7. - DOI - PMC - PubMed

LinkOut - more resources